Evidence map›Paper›PMID 35043148›Full record

ArticleDiabetes2022

Spatial Environment Affects HNF4A Mutation-Specific Proteome Signatures and Cellular Morphology in hiPSC-Derived β-Like Cells.

Manuel Carrasco, Chencheng Wang, Anne M Søviknes, Yngvild Bjørlykke, Shadab Abadpour, Joao A Paulo, Erling Tjora, Pål Njølstad, Jonas Ghabayen, Ingrid Nermoen and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Manuel CarrascoDepartment of Clinical Science, University of Bergen, Bergen, Norway.
Chencheng WangDepartment of Transplant Medicine and Institute for Surgical Research, Oslo University Hospital, Oslo, Norway.
Anne M SøviknesDepartment of Clinical Science, University of Bergen, Bergen, Norway.
Yngvild BjørlykkeDepartment of Clinical Science, University of Bergen, Bergen, Norway.
Shadab AbadpourDepartment of Transplant Medicine and Institute for Surgical Research, Oslo University Hospital, Oslo, Norway.ORCID 0000-0002-7567-7871
Joao A PauloDepartment of Cell Biology, Harvard Medical School, Boston, MA.
Erling TjoraDepartment of Clinical Science, University of Bergen, Bergen, Norway.
Pål NjølstadDepartment of Clinical Science, University of Bergen, Bergen, Norway.ORCID 0000-0003-0304-6728
Jonas GhabayenDepartment of Clinical Science, University of Bergen, Bergen, Norway.
Ingrid NermoenDepartment of Endocrinology, Akershus University Hospital, Lorenskog, Norway.
Valeriya LyssenkoDepartment of Clinical Science, University of Bergen, Bergen, Norway.ORCID 0000-0002-0198-6524
Simona CheraDepartment of Clinical Science, University of Bergen, Bergen, Norway.
Luiza M GhilaDepartment of Clinical Science, University of Bergen, Bergen, Norway.
Marc VaudelDepartment of Clinical Science, University of Bergen, Bergen, Norway.
Hanne ScholzDepartment of Transplant Medicine and Institute for Surgical Research, Oslo University Hospital, Oslo, Norway.
Helge RæderDepartment of Clinical Science, University of Bergen, Bergen, Norway.ORCID 0000-0001-9465-8580
University of Bergen · NOHaukeland University Hospital · NOOslo University Hospital · NOAkershus University Hospital · NOHarvard University · US

Funding

Advancing Multiplexed Isobaric Tag-based Strategies for Proteome ProfilingR01GM132129 · NIGMS · HARVARD MEDICAL SCHOOL · PI PAULO, JOAO A · 2019 to 2023
$1.7M
NIGMS NIH HHS R01 GM132129
6 · The paper itself

Abstract

Studies of monogenic diabetes are particularly useful because we can gain insight into the molecular events of pancreatic β-cell failure. Maturity-onset diabetes of the young 1 (MODY1) is a form of monogenic diabetes caused by a mutation in the HNF4A gene. Human-induced pluripotent stem cells (hiPSCs) provide an excellent tool for disease modeling by subsequently directing differentiation toward desired pancreatic islet cells, but cellular phenotypes in terminally differentiated cells are notoriously difficult to detect. Re-creating a spatial (three-dimensional [3D]) environment may facilitate phenotype detection. We studied MODY1 by using hiPSC-derived pancreatic β-like patient and isogenic control cell lines in two different 3D contexts. Using size-adjusted cell aggregates and alginate capsules, we show that the 3D context is critical to facilitating the detection of mutation-specific phenotypes. In 3D cell aggregates, we identified irregular cell clusters and lower levels of structural proteins by proteome analysis, whereas in 3D alginate capsules, we identified altered levels of glycolytic proteins in the glucose sensing apparatus by proteome analysis. Our study provides novel knowledge on normal and abnormal function of HNF4A, paving the way for translational studies of new drug targets that can be used in precision diabetes medicine in MODY.

Indexed as

Diabetes Mellitus, Type 2Induced Pluripotent Stem CellsAlginatesCapsulesHepatocyte Nuclear Factor 4HumansMutationProteomeAlginatesCapsulesHepatocyte Nuclear Factor 4HNF4A protein, humanProteome

Identifiers

PMID35043148
PMCPMC8965667
OpenAlexW4206061669

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.